Protein Tyrosine Kinase
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20524 | Zidesamtinib ( NVL-520 ) | 2739829-00-4 | ≧98.0% |  |
| Zidesamtinib ( NVL-520 ) is a novel brain-penetrant ROS1-selective tyrosine kinase in | ||||
| 20548 | Pimicotinib ( ABSK02 ) | 2253123-16-7 | ≧98.0% | _2253123-16-7.png) |
| Pimicotinib is a novel small molecule inhibitor of CSF-1R, which is orally available, | ||||
| 21238 | Seralutinib | 1619931-27-9 | 98% Min. |  |
| Seralutinib, also known as PK-10571 and GB002, is a Novel Inhaled Pdgfr Kinase Inhibi | ||||
| 17031303 | Tirabrutinib free base ( ONO-4059 ) | 1351636-18-4 | ≧98.0% | _1351636-18-4.png) |
| Tirabrutinib, also known as ONO-4059 is a potent and orally active Bruton agammaglobu | ||||
| 17012103 | Tirabrutinib HCl | 1439901-97-9 | ≧98.0% |  |
| ONO-4059 is a selective and novel inhibitor of BTK with IC50 2.2 nm, ONO-4059 binds t | ||||
| 24003 | NVL-655 ( ALK-IN-27 ) | 2739866-40-9 | ≧98.0% | .png) |
| NVL-655 is a novel, brain-penetrant, ALK-selective inhibitor that was designed to add | ||||
| 51803 | Semaxanib (SU5416) | 204005-46-9 | 98% | -cas-204005-46-9.png) |
| Semaxanib (SU5416) is a potent and selectiveVEGFR(Flk-1/KDR) inhibitor withIC50of 1.2 | ||||
| 20635 | ERAS-801 ( JGK-068S ) | 2490431-16-6 | ≧98.0% |  |
| ERAS-801 ( JGK-068S ) is a potent EGFR inhibitor. | ||||
| 24010 | Zasocitinib | 2272904-53-5 | ≧98.0% |  |
| Zasocitinib is under development for the treatment of moderate to severe plaque psori | ||||
| 24011 | Zongertinib | 2728667-27-2 | ≧98.0% |  |
| Zongertinib [BI 1810631] is a human epidermal growth factor receptor 2 (HER2) inhibit | ||||